The effects of antidepressants on human brain as detected by imaging studies. Focus on major depression.

Abstract:

:Recent brain imaging studies have shed light on understanding the pathogenesis of mood disorders. Evidence of structural, chemical, and functional brain changes, particularly in prefrontal cortex, cingulate, and amygdala, has been revealed in major depressive disorder (MDD). Furthermore, imaging techniques have been applied to monitor the effects of antidepressants (ADs) both in the brains of healthy volunteers and MDD patients. Although with some discrepancies due to the differences in study designs and patient samples, imaging findings have shown that ADs, particularly those having effects on the serotonergic system, modulate the volumes, functions and biochemistry of brain structures, i.e. dorsolateral prefrontal cortex, anterior cingulate and amygdala, which have been demonstrated abnormal in MDD by earlier imaging studies. This paper reviews imaging studies conducted in MDD patients and healthy controls treated with different ADs.

authors

Bellani M,Dusi N,Yeh PH,Soares JC,Brambilla P

doi

10.1016/j.pnpbp.2010.11.040

subject

Has Abstract

pub_date

2011-08-15 00:00:00

pages

1544-52

issue

7

eissn

0278-5846

issn

1878-4216

pii

S0278-5846(10)00471-9

journal_volume

35

pub_type

杂志文章,评审
  • Impact of juvenile chronic stress on adult cortico-accumbal function: Implications for cognition and addiction.

    abstract::Repeated exposure to stress during childhood is associated with increased risk for neuropsychiatric illness, substance use disorders and other behavioral problems in adulthood. However, it is not clear how chronic childhood stress can lead to emergence of such a wide range of symptoms and disorders in later life. One ...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章,评审

    doi:10.1016/j.pnpbp.2017.06.015

    authors: Watt MJ,Weber MA,Davies SR,Forster GL

    更新日期:2017-10-03 00:00:00

  • Changes of metallothionein I + II proteins in the brain after 1-methyl-4-phenylpyridinium administration in mice.

    abstract::1-methyl-4-phenylpyridinium (MPP+) is a drug that induces a Parkinson's-like syndrome in several species. Oxidative stress resulting from either excess generation or reduced scavenging of free radicals has been proposed to play a role in its neurotoxicity. It has been suggested that metallothionein (MT) protects again...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/s0278-5846(99)00077-9

    authors: Rojas P,Hidalgo J,Ebadi M,Rios C

    更新日期:2000-01-01 00:00:00

  • Believing is achieving - On the role of treatment expectation in neurofeedback applications.

    abstract::In neurofeedback applications, neural activity is recorded, processed in real-time and fed back to the user in order to facilitate self-regulation of the putative neural mechanisms that underlie cognition and behavior. Numerous studies suggest that neurofeedback interventions are an efficacious treatment particularly ...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/j.pnpbp.2020.110129

    authors: Schönenberg M,Weingärtner AL,Weimer K,Scheeff J

    更新日期:2021-03-08 00:00:00

  • Role of state-dependency in memory impairment induced by acute administration of midazolam in mice.

    abstract::Although the memory deficits produced by pre-training benzodiazepines administration have been extensively demonstrated both in humans and in animal studies, there is considerable controversy about the involvement of the state-dependency phenomenon on benzodiazepines-induced anterograde amnesia. The present study aime...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/j.pnpbp.2012.01.013

    authors: Sanday L,Zanin KA,Patti CL,Tufik S,Frussa-Filho R

    更新日期:2012-04-27 00:00:00

  • The value of cytidine-5-diphosphate-choline in the prevention of impairment of memory function after electric convulsive therapy. A double-blind study.

    abstract::1. A double-blind study of the effect of CDP-choline on memory impairment following bilateral ECT was performed on 22 inpatients suffering from endogenous depression. 2. Memory scores were checked after 2 and 4 ECT sessions, and the length of the post-ECT confusional state was also measured. 3. The results show no sta...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 临床试验,杂志文章

    doi:10.1016/s0278-5846(82)80174-7

    authors: Ayuso-Gutierrez JL,Saiz-Ruiz J

    更新日期:1982-01-01 00:00:00

  • The treatment and management of neuroleptic malignant syndrome.

    abstract::1. The neuroleptic malignant syndrome was initially described as a disorder specifically related to neuroleptic usage with frequent fatal outcome. The observations of variant or mild cases of this syndrome as well as case reports on neuroleptic-malignant-like syndromes in the absence of neuroleptics raises the issue o...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章,评审

    doi:10.1016/0278-5846(92)90051-f

    authors: Gratz SS,Levinson DF,Simpson GM

    更新日期:1992-07-01 00:00:00

  • SSRIs and conditioned fear.

    abstract::Among drugs that act on serotonergic neurotransmission, selective serotonin (5-HT) reuptake inhibitors (SSRIs) are now the gold standard for the treatment of anxiety disorders. The precise mechanisms of the anxiolytic actions of SSRIs are unclear. We reviewed the literature related to the effects of SSRIs and the neur...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章,评审

    doi:10.1016/j.pnpbp.2011.09.002

    authors: Inoue T,Kitaichi Y,Koyama T

    更新日期:2011-12-01 00:00:00

  • Increased inositol-monophosphatase activity by lithium treatment in bipolar patients.

    abstract::Inhibition of inositol monophosphatase (IMPase) enzyme is the target mechanism of action of lithium. However, increased activity of mRNA levels by lithium has been reported. These two diverse effects were shown after relatively short periods of lithium administration. The aim of this study was to observe the effect of...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/j.pnpbp.2004.01.020

    authors: Kaya N,Resmi H,Ozerdem A,Guner G,Tunca Z

    更新日期:2004-05-01 00:00:00

  • Consequences of monoamine oxidase inhibition: increased vesicular accumulation of dopamine and norepinephrine and increased metabolism by catechol-O-methyltransferase and phenolsulfotransferase.

    abstract::1. Male Sprague-Dawley rats were injected with saline, L-Dopa or pargyline. 2. Synaptic vesicles were prepared from whole brain homogenates. Catecholamines and their metabolites in brain tissues and in synaptic vesicles were measured by high performance liquid chromatography with electrochemical detection. 3. L-Dopa a...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/0278-5846(89)90147-4

    authors: Buu NT,Lussier C

    更新日期:1989-01-01 00:00:00

  • Environmental enrichment improves cognitive deficits in Spontaneously Hypertensive Rats (SHR): relevance for Attention Deficit/Hyperactivity Disorder (ADHD).

    abstract::The interaction between genes and environment seems to be relevant for the development of Attention Deficit/Hyperactivity Disorder (ADHD), one of the most prevalent childhood psychiatric diseases. The occurrence of ADHD is typically associated with poor academic performance, probably reflecting learning difficulties a...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/j.pnpbp.2009.06.012

    authors: Pamplona FA,Pandolfo P,Savoldi R,Prediger RD,Takahashi RN

    更新日期:2009-10-01 00:00:00

  • Is quality of life associated with cognitive impairment in schizophrenia?

    abstract:BACKGROUND:The subjectively assessed quality of life of schizophrenia patients is mostly lower than healthy subjects, and cognitive impairment is an integral feature of schizophrenia. The aims of the present study were to compare the quality of life and neurocognitive functioning between the patients with schizophrenia...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/j.pnpbp.2004.11.006

    authors: Alptekin K,Akvardar Y,Kivircik Akdede BB,Dumlu K,Işik D,Pirinçci F,Yahssin S,Kitiş A

    更新日期:2005-02-01 00:00:00

  • Neurophysiological maturation deficit in behaviour disorder of children--an electrographic study.

    abstract::1. The investigations in biological factors of childrens' behaviour disorder are becoming increasingly important as their significance in clinical management is being recognized with more precision and clarity. 2. One of such electroencephalographic investigations is finding of some delay or defect in chronological ma...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/s0278-5846(82)80145-0

    authors: Singh AN

    更新日期:1982-01-01 00:00:00

  • The effect of haloperidol on met-enkephalin, beta-endorphin, cholecystokinin and substance P in the pituitary, the hypothalamus and the striatum of rats during aging.

    abstract::1. Haloperidol increased the Met-enk level in the striatum at all age groups. However, the Met-enk level was decreased in AL of young and middle-aged rats by the drug. 2. Haloperidol elevated the beta-end level in AL and CCK level in NIL in young rats only. 3. The SP content in NIL was decreased by haloperidol in all ...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/0278-5846(95)00234-0

    authors: Lau SM,Tang F

    更新日期:1995-11-01 00:00:00

  • Using model fish to study the biological mechanisms of cooperative behaviour: A future for translational research concerning social anxiety disorders?

    abstract::Human societies demand of its composing members the development of a wide array of social tools and strategies. A notable example is human outstanding ability to cooperate with others, in all its complex forms, depicting the reality of a highly demanding social framework in which humans need to be integrated as to att...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章,评审

    doi:10.1016/j.pnpbp.2017.11.014

    authors: Soares MC,Cardoso SC,Carvalho TDS,Maximino C

    更新日期:2018-03-02 00:00:00

  • Pharmacotherapy for major depression in children and adolescents.

    abstract::Major depression is a serious illness in children which adversely effects their social, academic, and emotional development. It is essential to identify safe and effective medication for the treatment of this disorder in youths. Only some selective serotonin reuptake inhibitors (citalopram, fluoxetine, sertraline) hav...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章,评审

    doi:10.1016/j.pnpbp.2005.03.005

    authors: Wagner KD

    更新日期:2005-06-01 00:00:00

  • Citalopram for social phobia: a clinical case series.

    abstract::Social anxiety disorder is a common illness with significant associated disability. Serotonin selective reuptake inhibitors (SSRIs) have become first-line treatment given their improved tolerability; however, there are few reports on the use of citalopram. Nine consecutive patients with a primary diagnosis of DSM-IV g...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/s0278-5846(01)00189-0

    authors: Simon NM,Sharma SG,Worthington JJ,Marzol PC,Pollack MH

    更新日期:2001-10-01 00:00:00

  • Corticosterone-attenuating and anxiolytic properties of mecamylamine in the rat.

    abstract::1. The available evidence suggests that stress induced release of acetylcholine (ACh) in the brain has a significant role in mediating neuroendocrine, emotional, and physiological responses to stress. Recent findings also suggest that stress indirectly (via acetylcholine) and nicotine directly stimulates the HPA axis ...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/s0278-5846(00)00178-0

    authors: Newman MB,Nazian SJ,Sanberg PR,Diamond DM,Shytle RD

    更新日期:2001-04-01 00:00:00

  • Panic disorder: response to sodium lactate and treatment with antidepressants.

    abstract::Effective drugs for mental disorders have been found by serendipitous findings not supported by knowledge of psychopharmacology. Drug are assigned labels, such as "antidepressant" without knowledge that such a label delimits the utility of such agents. Many double-blind controlled studies have shown that imipramine ef...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章,评审

    doi:10.1016/0278-5846(85)90177-0

    authors: Rifkin A,Siris SG

    更新日期:1985-01-01 00:00:00

  • Drugs of abuse and Parkinson's disease.

    abstract::The term "drug of abuse" is highly contextual. What constitutes a drug of abuse for one population of patients does not for another. It is therefore important to examine the needs of the patient population to properly assess the status of drugs of abuse. The focus of this article is on the bidirectional relationship b...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章,评审

    doi:10.1016/j.pnpbp.2015.03.013

    authors: Mursaleen LR,Stamford JA

    更新日期:2016-01-04 00:00:00

  • Moclobemide, an inhibitor of MAO-A, does not increase daytime plasma melatonin levels in normal humans.

    abstract::1. Plasma melatonin concentrations were determined after administration of single oral doses (100, 200 and 300 mg) of moclobemide, a reversible inhibitor of monoamine oxidase (MAO) with predominant effects on the A-type of the enzyme, to eight young, healthy male volunteers in a double-blind, random-order, placebo-con...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0278-5846(90)90065-o

    authors: Scheinin M,Koulu M,Vakkuri O,Vuorinen J,Zimmer RH

    更新日期:1990-01-01 00:00:00

  • Propranolol in schizophrenia.

    abstract::1. 15 schizophrenic patients diagnosed according to criteria of I.C.D.-9 were treated with d1-propranolol in a 4 week open study. 2. A fixed dose schedule was followed and a maximum dose of 1920 mg/day was reached by day 17. 3. Results revealed a significant reduction in core schizophrenic symptoms of CPRS & BPRS star...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/0278-5846(83)90093-3

    authors: Sethi BB,Dubé S

    更新日期:1983-01-01 00:00:00

  • Whole-body hyperthermia and a subthreshold dose of citalopram act synergistically to induce antidepressant-like behavioral responses in adolescent rats.

    abstract:BACKGROUND:Open and randomized, double blind, placebo-controlled clinical trials have demonstrated clinical efficacy of infrared whole-body hyperthermia in treatment of major depressive disorder (MDD). Demonstration of antidepressant-like behavioral effects of whole-body hyperthermia in preclinical rodent models would ...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/j.pnpbp.2017.06.006

    authors: Hale MW,Lukkes JL,Dady KF,Kelly KJ,Paul ED,Smith DG,Raison CL,Lowry CA

    更新日期:2017-10-03 00:00:00

  • Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: An open-label pilot study.

    abstract:OBJECTIVE:The aim of this study was to investigate whether augmentation of clozapine with aripiprazole improves clinically significant residual symptoms in stabilized outpatients with chronic schizophrenia. METHODS:Twenty seven stabilized outpatients meeting criteria for chronic schizophrenia, who had residual symptom...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.pnpbp.2006.09.015

    authors: Mitsonis CI,Dimopoulos NP,Mitropoulos PA,Kararizou EG,Katsa AN,Tsakiris FE,Katsanou MN

    更新日期:2007-03-30 00:00:00

  • Heart rate variability in drug-naïve patients with panic disorder and major depressive disorder.

    abstract::Power spectral analysis of electrocardiogram (ECG) R-R intervals is useful for the detection of autonomic dysfunction in various clinical disorders. Although both panic disorder (PD) and major depressive disorder (MDD) are known to have effects on the cardiac autonomic nervous system, no previous study has tested this...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/j.pnpbp.2009.08.002

    authors: Kikuchi M,Hanaoka A,Kidani T,Remijn GB,Minabe Y,Munesue T,Koshino Y

    更新日期:2009-11-13 00:00:00

  • Neurodevelopmental basis of bipolar disorder: a critical appraisal.

    abstract::Neurodevelopmental factors have been implicated in the pathophysiology of mental disorders. However, the evidence regarding their role in bipolar disorder is controversial. We reviewed the pertinent literature searching for evidence regarding a neurodevelopmental origin of bipolar disorder. Findings from clinical, epi...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章,评审

    doi:10.1016/j.pnpbp.2008.04.017

    authors: Sanches M,Keshavan MS,Brambilla P,Soares JC

    更新日期:2008-10-01 00:00:00

  • Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end?

    abstract::Group II metabotropic glutamate receptor (mGluR2/3) agonists once showed promise as non-dopaminergic antipsychotic drugs because of their efficacy in alleviating symptoms of schizophrenia (SZ) in both animal models and human patients. However, the recent failure of Phase III clinical trials dealt a huge blow to the sc...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章,评审

    doi:10.1016/j.pnpbp.2015.02.012

    authors: Li ML,Hu XQ,Li F,Gao WJ

    更新日期:2015-07-03 00:00:00

  • Clinical strategies for evaluating ECT mechanisms--pharmacological, biochemical and psychophysiological approaches.

    abstract::Although ECT is a highly effective treatment for severe depression and other psychiatric syndromes, its mode of action is not known. Recent studies have suggested that effects of ECT on central neurotransmitter receptors may underlie its therapeutic action. The effects of chronically administered electroconvulsive sho...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/0278-5846(83)90120-3

    authors: Lerer B,Sitaram N

    更新日期:1983-01-01 00:00:00

  • Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression.

    abstract:BACKGROUND:Gene expressions of the peripheral leukocytes in depressive patients might reflect the systemic dysfunction of major depression. We determined mRNA expression levels of Histone deacetylase 5 (HDAC5) gene and cyclic AMP response element-binding protein 1 (CREB) gene in the leukocyte of depressive patients. HD...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/j.pnpbp.2006.12.014

    authors: Iga J,Ueno S,Yamauchi K,Numata S,Kinouchi S,Tayoshi-Shibuya S,Song H,Ohmori T

    更新日期:2007-04-13 00:00:00

  • A survey of prescribing practices in the treatment of depression.

    abstract:BACKGROUND:With the increasing number and type of antidepressants available to clinicians, there is a need to better understand current prescribing practices and to what degree these practices reflect research findings. The purpose of this study was to examine prescribing practices in a sample of psychiatrists attendin...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/s0278-5846(01)00250-0

    authors: Petersen T,Dording C,Neault NB,Kornbluh R,Alpert JE,Nierenberg AA,Rosenbaum JF,Fava M

    更新日期:2002-01-01 00:00:00

  • Roles of olfactory system dysfunction in depression.

    abstract::The olfactory system is involved in sensory functions, emotional regulation and memory formation. Olfactory bulbectomy in rat has been employed as an animal model of depression for antidepressant discovery studies for many years. Olfaction is impaired in animals suffering from chronic stress, and patients with clinica...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章,评审

    doi:10.1016/j.pnpbp.2014.05.013

    authors: Yuan TF,Slotnick BM

    更新日期:2014-10-03 00:00:00